Nanomedicine and Pharmaceutical Nanotechnology

Nano pharmaceutical Regulations

The successful development of nanopharmaceuticals requires robust regulatory frameworks to ensure product quality, safety, and efficacy. This session will examine global regulatory guidelines, quality standards, risk assessment methodologies, and approval pathways for nanomedicine products. Topics include manufacturing practices, characterization techniques, clinical evaluation, and post-market surveillance. Regulatory professionals, researchers, and industry stakeholders will discuss current challenges and emerging regulatory trends. The session provides valuable insights into navigating the complex regulatory landscape and supporting the responsible development of innovative nanopharmaceutical products.